Company Filing History:
Years Active: 1993
Title: Mose DaPrada: Innovator in Pharmacological Chemistry
Introduction
Mose DaPrada is a notable inventor based in Riehen, Switzerland. He has made significant contributions to the field of pharmacological chemistry, particularly through his innovative work on catechol derivatives. His research focuses on compounds that possess valuable pharmacological properties, which can have a profound impact on therapeutic applications.
Latest Patents
Mose DaPrada holds a patent for catechol derivatives, specifically those that inhibit the enzyme catechol-O-methyltransferase (COMT). This enzyme plays a crucial role in the metabolism of catecholamines and other therapeutically active substances. The patent describes various ester and ether derivatives that are hydrolyzable under physiological conditions, along with their pharmaceutically acceptable salts. These compounds can be utilized to deactivate extraneuornal catecholamines and enhance the efficacy of therapeutic agents.
Career Highlights
Throughout his career, Mose DaPrada has been associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work has contributed to advancements in drug development and has positioned him as a key figure in pharmacological research.
Collaborations
Mose DaPrada has collaborated with esteemed colleagues such as Karl Bernauer and Janos Borgulya. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmacology.
Conclusion
Mose DaPrada's contributions to the field of pharmacological chemistry through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of therapeutic agents that can improve patient outcomes.